phenylephrine has been researched along with Cirrhosis in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (13.79) | 18.2507 |
| 2000's | 5 (17.24) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 10 (34.48) | 2.80 |
| Authors | Studies |
|---|---|
| Aşan, M; Gur, S; Kaya-Sezginer, E; Kırlangıç, OF; Özen, FZ; Yilmaz, S; Yilmaz-Oral, D | 1 |
| Apte, SS; Bhutada, S; Chen, J; DeAngelo, LP; Gojanovich, GS; Hara, A; Heckl, JR; Hokutan, K; Jahansooz, JR; Kuwabara, JT; Lee, AY; Shettigar, V; Tacdol, DK; Tallquist, MD; Ziolo, MT | 1 |
| Funamoto, M; Hamabe-Horiike, T; Hasegawa, K; Katanasaka, Y; Kawaguchi, S; Kawase, Y; Komiyama, M; Miyazaki, Y; Mori, K; Morimoto, T; Murakami, A; Shimizu, K; Shimizu, S; Sunagawa, Y | 1 |
| Alharbi, HO; Clerk, A; Cooper, STE; Cull, JJ; Fuller, SJ; Glennon, PE; Hardyman, MA; Markou, T; Sugden, PH | 1 |
| Kokkonen-Simon, K; Kovacs, A; Li, T; Matkovich, SJ; Matsiukevich, D; Oladipupo, SS; Ornitz, DM | 1 |
| Chen, Y; Feng, X; Hou, H; Xu, G; Yan, M | 1 |
| Hill, JA | 1 |
| Chen, Z; He, X; Liu, X; Lu, Y; Miao, R; Wang, J | 1 |
| An, P; Fan, D; Guo, Z; Hasan, SG; Liu, FY; Ma, SQ; Tang, N; Tang, QZ; Wang, MY; Wu, HM; Yang, D; Yang, Z | 1 |
| Chen, Y; Fu, X; Guo, J; Liang, T; Pan, R; Sun, T; Wang, L; Zhang, J; Zhang, L | 1 |
| Ham, W; Kang, CW; Kang, H; Kim, J; Lee, WS; Ock, S | 1 |
| Chen, X; Cui, S; Cui, Y; Ding, S; Guo, H; Li, Y; Qin, W; Wang, H; Wu, D; Zhang, Y | 1 |
| Duan, W; Feng, P; Gao, E; Jin, Z; Liang, H; Liu, J; Sun, Y; Tan, Y; Wang, X; Yi, D; Yi, W; Yu, S; Zhang, B; Zhang, P; Zhang, Z | 1 |
| Cai, ZL; Deng, W; Duan, MX; Liu, C; Tang, QZ; Wu, QQ; Xie, QW; Xie, SY; Yuan, Y | 1 |
| Böhm, M; Devaux, Y; Fries, P; Kazakov, A; Maack, C; Müller, A; Puhl, SL; Wagner, DR | 1 |
| Bloch, DB; Bloch, KD; Buys, ES; Cheng, J; Ernande, L; Kolodziej, SA; Leyton, PA; Mayeur, C; Rhee, DK; Scherrer-Crosbie, M; Shahid, M; Spagnolli, E; Tainsh, RE; Thoonen, R; Wu, MX; Zapol, WM | 1 |
| Bethmann, D; Gekle, M; Heise, C; Mildenberger, S; Rabe, S; Schreier, B; Schwerdt, G | 1 |
| Bin, J; Chen, Z; Hao, H; Huang, X; Kitakaze, M; Li, Q; Li, X; Liao, W; Liao, Y; Lin, H; Xie, J; Xuan, W | 1 |
| Cha, H; Choi, BY; Hajjar, RJ; Jang, SP; Jeong, D; Jeong, MH; Kim, J; Lee, MA; Park, WJ; Yang, DK; Yoon, PO | 1 |
| Askar, SF; Atsma, DE; Bingen, BO; de Vries, AA; Pijnappels, DA; Schalij, MJ; Schutte, CI; Swildens, J; Ypey, DL; Zeppenfeld, K | 1 |
| Kawahara, Y; Maki, T; Takeo, S; Tanonaka, K; Yagi, A | 1 |
| Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H | 1 |
| Ikeda, K; Leinwand, LA; Maass, AH; Maier, SK; Oberdorf-Maass, S | 1 |
| Fahim, M; Omanwar, S; Rizvi, MR; Sarin, SK | 1 |
| Arimoto, T; Bilim, O; Goto, K; Ishino, M; Kitahara, T; Kubota, I; Nakajima, O; Niizeki, T; Sasaki, T; Suzuki, S; Takeishi, Y; Walsh, RA | 1 |
| Jacobs, MJ; Klopper, PJ; Kromhout, JG; Pfaffendorf, M; Van Gulik, TM; Van Marle, J; Van Zwieten, PA; Vischjager, M | 1 |
| Brecher, P; Chobanian, AV; Crawford, DC; Farivar, RS | 1 |
| Benessiano, J; Caputo, L; Duriez, M; Henrion, D; Heymes, C; Levy, BI; Poitevin, P; Samuel, JL | 1 |
| Berecek, KH; Bishop, SP; Gelband, CH; Katovich, MJ; Lu, D; Martens, JR; Raizada, MK; Reaves, PY | 1 |
29 other study(ies) available for phenylephrine and Cirrhosis
| Article | Year |
|---|---|
Sodium butyrate ameliorates erectile dysfunction through fibrosis in a rat model of partial bladder outlet obstruction.
Topics: Animals; Butyric Acid; Disease Models, Animal; Erectile Dysfunction; Fibrosis; Histone Deacetylases; Humans; Inflammation; Male; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type III; Penis; Phenylephrine; Prostatic Hyperplasia; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Transforming Growth Factors; Tumor Necrosis Factor-alpha; Urinary Bladder Neck Obstruction | 2022 |
Consequences of PDGFRα
Topics: Angiotensin II; Animals; Calcium; Collagen; Fibroblasts; Fibrosis; Mice; Myocardial Infarction; Myocardium; Phenylephrine; Proteome; Receptor, Platelet-Derived Growth Factor alpha | 2022 |
Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARα in rats.
Topics: Animals; Atrial Natriuretic Factor; Biological Products; Cardiomegaly; Citrus; Coumarins; Endothelin-1; Fibrosis; Heart Failure; Myocardial Infarction; Peroxisome Proliferators; Phenylephrine; PPAR alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2022 |
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.
Topics: Animals; Cardiomegaly; Female; Fibrosis; Hypertension; Male; Mice; Myocytes, Cardiac; Phenylephrine; Proto-Oncogene Proteins B-raf; Tamoxifen | 2022 |
Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Topics: Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Failure; Mice; Phenylephrine; Stroke Volume; Ventricular Function, Left | 2023 |
Tripartite motif‑containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice.
Topics: Animals; Animals, Newborn; Cardiomegaly; Fibrosis; Glycogen Synthase Kinase 3 beta; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Proto-Oncogene Proteins c-akt; Rats; Tripartite Motif Proteins | 2023 |
When the CAR Targets Scar.
Topics: Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Immunotherapy, Adoptive; Mice; Mice, Mutant Strains; Myocardium; Phenylephrine; Receptors, Chimeric Antigen | 2019 |
Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Topics: Angiotensin II; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomegaly; CRISPR-Cas Systems; Disease Models, Animal; Endopeptidases; Fibrosis; Inflammation; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phenylephrine; Pressure; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Ubiquitin-Protein Ligases; Ventricular Remodeling | 2020 |
6-Gingerol protects against cardiac remodeling by inhibiting the p38 mitogen-activated protein kinase pathway.
Topics: Animals; Anti-Inflammatory Agents; Cardiomegaly; Cardiotonic Agents; Catechols; Fatty Alcohols; Fibroblasts; Fibrosis; Inflammation; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ventricular Remodeling | 2021 |
Pinoresinol diglucoside (PDG) attenuates cardiac hypertrophy via AKT/mTOR/NF-κB signaling in pressure overload-induced rats.
Topics: Animals; Animals, Newborn; Aorta, Abdominal; Cardiomegaly; Constriction, Pathologic; Disease Models, Animal; Fibrosis; Inflammation; Isoproterenol; Lignans; Male; Myocytes, Cardiac; NF-kappa B; Phenylephrine; Pressure; Primary Cell Culture; Proto-Oncogene Proteins c-akt; Rats, Sprague-Dawley; Signal Transduction; TOR Serine-Threonine Kinases; Ventricular Remodeling | 2021 |
IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA.
Topics: Actins; Angiotensin II; Animals; Cardiomyopathies; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Infusions, Intravenous; Insulin-Like Growth Factor I; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Phenylephrine; Proto-Oncogene Proteins c-akt; Rats; Receptor, IGF Type 1; rho-Associated Kinases; Signal Transduction | 2021 |
Inhibition of cardiac hypertrophy by aromadendrin through down-regulating NFAT and MAPKs pathways.
Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Down-Regulation; Fibrosis; Flavonoids; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Pressure; Protein Biosynthesis | 2018 |
C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
Topics: Adipokines; Animals; Animals, Newborn; Aorta; Cardiomegaly; Constriction, Pathologic; Cyclic AMP Response Element-Binding Protein; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Fibrosis; Male; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Rats, Sprague-Dawley; Signal Transduction; Up-Regulation | 2019 |
Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Cardiomegaly; Cells, Cultured; Fibrosis; Guaiacol; Heart Failure; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oxidative Stress; Phenylephrine; Rats; Signal Transduction; Ventricular Remodeling | 2019 |
Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adrenergic alpha-1 Receptor Agonists; Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cell Culture Techniques; Dose-Response Relationship, Drug; Fibrosis; Insulin-Like Growth Factor I; Male; Matrix Metalloproteinase 2; Mice; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; Rats; Receptor, Adenosine A1; Up-Regulation | 2016 |
BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
Topics: Activin Receptors, Type I; Activin Receptors, Type II; Angiotensin II; Animals; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors, Type I; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Inhibitor of Differentiation Protein 1; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Phosphorylation; Pyrazoles; Pyrimidines; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Smad Proteins; Time Factors; Transfection | 2016 |
Substance-specific importance of EGFR for vascular smooth muscle cells motility in primary culture.
Topics: Adenosine Triphosphate; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Endothelin-1; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Fibrosis; Gene Expression Regulation; Genotype; Inflammation; Ligands; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phenotype; Phenylephrine; Primary Cell Culture; Signal Transduction; Thrombin; Time Factors; Vasopressins | 2016 |
FGF23 promotes myocardial fibrosis in mice through activation of β-catenin.
Topics: Angiotensin II; Animals; beta Catenin; Cells, Cultured; Collagen; Dependovirus; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibrosis; Humans; Hypertrophy, Left Ventricular; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptor, Fibroblast Growth Factor, Type 4; Reperfusion Injury; RNA, Small Interfering; Transforming Growth Factor beta; Up-Regulation | 2016 |
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Topics: Animals; Cardiomegaly; Cells, Cultured; Connective Tissue Growth Factor; Fibrosis; Heart Failure; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Phenylephrine; Pressure; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2010 |
Similar arrhythmicity in hypertrophic and fibrotic cardiac cultures caused by distinct substrate-specific mechanisms.
Topics: Action Potentials; Animals; Animals, Newborn; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiomegaly; Cells, Cultured; Coculture Techniques; Connexin 43; Fibroblasts; Fibrosis; Gap Junctions; Kinetics; Myocytes, Cardiac; Patch-Clamp Techniques; Phenylephrine; Rats; Shal Potassium Channels; Voltage-Sensitive Dye Imaging | 2013 |
Effects of tanshinone VI on the hypertrophy of cardiac myocytes and fibrosis of cardiac fibroblasts of neonatal rats.
Topics: Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Collagen; Endothelin-1; Female; Fibroblasts; Fibrosis; Insulin-Like Growth Factor I; Leucine; Male; Myocytes, Cardiac; Paracrine Communication; Phenanthrenes; Phenylephrine; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Salvia miltiorrhiza; Tritium | 2002 |
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents | 2004 |
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Amino Acid Substitution; Angiotensin II; Animals; Body Weight; Cardiomyopathy, Hypertrophic, Familial; Cell Size; Death, Sudden, Cardiac; Female; Fibrosis; Gene Expression Profiling; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Mutation, Missense; Myocytes, Cardiac; Organ Size; Phenotype; Phenylephrine; Point Mutation; Protein Isoforms; RNA Splice Sites; RNA, Messenger; Sex Characteristics; Troponin T | 2004 |
Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model of E. coli injection.
Topics: Acetylcholine; Animals; Disease Models, Animal; Escherichia coli; Fibrosis; Hypertension, Portal; Injections; Lipopolysaccharides; Phenylephrine; Rabbits; Vasoconstriction | 2007 |
Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Cardiomegaly; Diacylglycerol Kinase; Diglycerides; Disease Models, Animal; Disease Progression; Fetal Proteins; Fibrosis; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Isoenzymes; Ligation; Mice; Mice, Transgenic; Myocardium; Organ Size; Phenylephrine; Protein Kinase C; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel; Ventricular Function, Left | 2008 |
Morphology and function of dog arterial grafts preserved in UW-solution.
Topics: Adenosine; Allopurinol; Animals; Carotid Arteries; Cold Temperature; Dogs; Endothelium, Vascular; Female; Fibrosis; Glutathione; Insulin; Methacholine Chloride; Microscopy, Electron, Scanning; Muscarinic Agonists; Muscle, Smooth, Vascular; Organ Preservation Solutions; Phenylephrine; Raffinose; Sodium Chloride; Time Factors; Tissue Preservation; Tissue Survival; Transplantation, Autologous; Transplantation, Homologous; Vascular Patency; Vasoconstrictor Agents; Veins | 1995 |
Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blotting, Northern; Fibrosis; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Phenylephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Renin-Angiotensin System; RNA; Tetrazoles | 1995 |
Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Collagen; Elastin; Fibrosis; Hypertension; Hypertrophy; Imidazoles; Infusions, Parenteral; Losartan; Male; Muscle, Smooth, Vascular; Phenylephrine; Pyridines; Rats; Rats, Wistar; Reference Values; Tetrazoles | 1996 |
Prevention of renovascular and cardiac pathophysiological changes in hypertension by angiotensin II type 1 receptor antisense gene therapy.
Topics: Acetylcholine; Animals; Animals, Newborn; Blood Pressure; Cardiomegaly; Coronary Vessels; DNA, Antisense; Fibrosis; Genetic Therapy; Genetic Vectors; Heart; Heart Ventricles; Humans; Hypertension; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Myocardium; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renal Artery; Retroviridae | 1998 |